| 000 | 01151 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250511233016.0 | ||
| 264 | 0 | _c19910411 | |
| 008 | 199104s 0 0 eng d | ||
| 022 | _a0042-9007 | ||
| 024 | 7 |
_a10.1111/j.1423-0410.1990.tb00248.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLe Pont, F | |
| 245 | 0 | 0 |
_aAnti-HBc testing can decrease the residual risk of transfusion-related HIV transmission by more than one third. _h[electronic resource] |
| 260 |
_bVox sanguinis _c1990 |
||
| 300 |
_a248-50 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aBlood Donors |
| 650 | 0 | 4 |
_aHIV Infections _xtransmission |
| 650 | 0 | 4 |
_aHepatitis Antibodies _xanalysis |
| 650 | 0 | 4 |
_aHepatitis B Core Antigens _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTransfusion Reaction |
| 700 | 1 | _aMassari, V | |
| 700 | 1 | _aJullien, A M | |
| 700 | 1 | _aCostagliola, D | |
| 700 | 1 | _aValleron, A J | |
| 773 | 0 |
_tVox sanguinis _gvol. 59 _gno. 4 _gp. 248-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1423-0410.1990.tb00248.x _zAvailable from publisher's website |
| 999 |
_c2299541 _d2299541 |
||